LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "janssen" as a keyword



Photo from wikipedia

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

Sign Up to like & get
recommendations! Published in 2020 at "American Journal of Hematology"

DOI: 10.1002/ajh.25864

Abstract: E.E.M.: Consulting fees from Adaptive Biotechnologies, Celgene, Takeda, Sanofi, Janssen; Research Funding to University of Texas MD Anderson from: Merck, Quest Diagnostics, Sanofi, JW Pharma. M.I.W.: consulting for Acerta Pharma, Janssen; Research Funding to UT… read more here.

Keywords: patients newly; methotrexate cytarabine; janssen; research funding ... See more keywords
Photo by jannerboy62 from unsplash

LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.100_2629

Abstract: Janssen. Hodkinson, B: Employment Leadership Position: Janssen R&D. Schaffer, M: Employment Leadership Position: Janssen; Stock Ownership: Janssen. Sehn, L: Consultant Advisory Role: Celgene, AbbVie, Seattle Genetics, TG Therapeutics, Janssen, Amgen, Roche/Genentech, Gilead Sciences, Lundbeck, Apobiologix,… read more here.

Keywords: employment leadership; janssen; leadership position; johnson ... See more keywords
Photo by _louisreed from unsplash

ARGO: A RANDOMISED PHASE II STUDY OF ATEZOLIZUMAB WITH RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT CANDIDATES FOR HIGH‐DOSE THERAPY

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.1_2632

Abstract: Roche, Janssen, Takeda, MSD, Gilead, Bristol Myers Squibb, AstraZenecca; Research Funding: Celgene, Roche, Abbvie; Other Remuneration: Roche, Amgen. Chu, M: Honoraria: AstraZeneca, Gilead, Celgene. Dreyling, M: Honoraria: Bayer, Celgene, Gilead, Janssen, Roche, Acerta, Bayer, Celgene,… read more here.

Keywords: janssen; roche; research funding; celgene ... See more keywords
Photo by mohammadshahhosseini from unsplash

Evaluation of markers associated with efficacy of abiraterone acetate plus prednisone (AAP) in patients (pts) with castration-sensitive prostate cancer (mCSPC) from the LATITUDE study

Sign Up to like & get
recommendations! Published in 2019 at "Annals of Oncology"

DOI: 10.1093/annonc/mdz239.006

Abstract: Abstract Background AAP and androgen deprivation therapy (ADT) treatment significantly improved overall survival (OS) and radiological progression-free survival (rPFS) in mCSPC pts with adverse prognostic factors. This analysis was aimed to identify predictive markers associated… read more here.

Keywords: consultancy received; received personal; janssen; advisory consultancy ... See more keywords
Photo from wikipedia

P135 Efficacy and safety of upadacitinib in TNFi inadequate responders with rheumatoid arthritis from three Phase 3 clinical trials

Sign Up to like & get
recommendations! Published in 2023 at "Rheumatology"

DOI: 10.1093/rheumatology/kead104.176

Abstract: For patients with RA who are refractory to biologic disease-modifying antirheumatic drugs (bDMARDs), such as tumor necrosis factor inhibitors (TNFis), optimal disease control is less likely to be achieved with subsequent therapy. In line with… read more here.

Keywords: bristol; amgen; abbvie amgen; janssen ... See more keywords
Photo from wikipedia

P169 Treatment effects of ixekizumab and adalimumab at the individual digit level with nail and distal interphalangeal joint involvement in patients with psoriatic arthritis

Sign Up to like & get
recommendations! Published in 2023 at "Rheumatology"

DOI: 10.1093/rheumatology/kead104.210

Abstract: Psoriatic nail disease is intimately linked to adjacent distal interphalangeal joint (DIP) disease, and it is important to ascertain whether DIP-nail complex behaves differently under different biological therapies. The aim of this analysis is to… read more here.

Keywords: lilly company; novartis; involvement; janssen ... See more keywords
Photo from wikipedia

SAT0348 Safety of ixekizumab in patients with psoriatic arthritis: results from a pooled analysis of three clinical trials

Sign Up to like & get
recommendations! Published in 2018 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2018-eular.2132

Abstract: Background Ixekizumab (IXE), a high affinity monoclonal antibody that selectively targets interleukin-17A, has been shown to be superior to placebo (PBO) in improving signs and symptoms of psoriatic arthritis (PsA) in Phase 3 trials1, 2.… read more here.

Keywords: pfizer; lilly company; eli lilly; janssen ... See more keywords
Photo by mohammadshahhosseini from unsplash

AB0945 Secukinumab efficacy in patients with active psoriatic arthritis: pooled analysis of four phase 3 trials by prior anti-tnf therapy and concomitant methotrexate use

Sign Up to like & get
recommendations! Published in 2018 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2018-eular.2374

Abstract: Background Secukinumab has demonstrated rapid, significant and sustained improvement in the signs and symptoms of psoriatic arthritis (PsA) in multiple Phase 3 studies.1–3 Objectives To report pooled efficacy results for secukinumab versus placebo at Week… read more here.

Keywords: celgene; anti tnf; janssen; novartis ... See more keywords

AB0955 Tildrakizumab efficacy over time by week 28 response levels in two phase 3 clinical trials in patients with chronic plaque psoriasis

Sign Up to like & get
recommendations! Published in 2018 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2018-eular.2983

Abstract: Background Tildrakizumab (TIL), a high affinity, humanised, IgG1/κ monoclonal antibody for IL-23p19, recently demonstrated efficacy in patients with chronic plaque psoriasis in two, phase 3 clinical trials. Objectives To examine efficacy from baseline to week… read more here.

Keywords: week; pfizer; celgene; pasi pasi ... See more keywords
Photo by _louisreed from unsplash

AB0928 Ustekinumab and tnf inhibitors in psoriatic arthritis: first follow-up data from a routine care study in 8 european countries (PSABIO)

Sign Up to like & get
recommendations! Published in 2018 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2018-eular.6939

Abstract: Background The purpose of PsABio (ClinicalTrials.gov Id: NCT02627768) is to evaluate the efficacy, tolerability and persistence of TNF inhibitors (TNFi) and ustekinumab (UST) for patients with psoriatic arthritis (PsA) starting 1st, 2nd or 3rd line… read more here.

Keywords: celgene; janssen; research support; pfizer ... See more keywords
Photo from wikipedia

FRI0065 PATIENT-REPORTED PALINDROMIC SYMPTOMS IN EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE CANADIAN EARLY ARTHRITIS COHORT

Sign Up to like & get
recommendations! Published in 2019 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2019-eular.2458

Abstract: Background The frequency and characteristics of patients with Palindromic Rheumatism (PR) (transient acute attacks of articular inflammation) prior to early rheumatoid arthritis (ERA) are unknown. Objectives To compare ERA patients who did versus did not… read more here.

Keywords: pfizer; inc; janssen; consultant ... See more keywords